﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>34</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>01</Month>
        <DAY>28</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Counteraction Effect of Endogenous Serotonin and Cyclic Guanosine Mono Phosphate on the Anxiety Level in Mice</ArticleTitle>
    <FirstPage>41</FirstPage>
    <LastPage>45</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Siamak Shahidi</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Nasrin Hashemi-Firouzi</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>Minoo Mahmoodi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>01</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: Selective serotonin reuptake inhibitors are widely used as anti-depressant but some adverse effects such as anxiety and sexual dysfunction have been reported. On the other hand, the effect of sildenafil, a phosphodiesterase inhibitor, which increase nitric oxide on the anxiety is controversial and there is an interaction between serotonergic systems with NO-cGMP pathway. The aim of this study was to evaluate the synergic effects of co-administration of fluoxetine and sildenafil on anxiety. Materials and Methods: In this experimental study, investigated on male mice (20-35 g) into control and experimental groups. The experimental groups received fluoxetine (20, 10 and 5 mg/kg), or a combination of fluoxetine (20, 10 and 5 mg/kg) sildenafil (10, 2 and 1 mg/kg) control group saline was injected intraperitoneally (i.p.) fifteen minutes prior placing in the Elevated plus-maze. The time spent in the open arms, number of entries in the open arms and number of total entries into the arms was measured. Results: Administration of fluoxetine decreased the time spent and number of entries into the open arms. There is no significant difference in those measurable variables in co-administration of fluoxetine and sildenafil compared with control group. Conclusion: Co-administration of fluoxetine and sildenafil has no therapeutic effect on anxiety. It seems that co-administration of sildenafil decreases the anxieogenic effect of fluoxetine.</Abstract>
  </Article>
</ArticleSet>